Sakti Cjakrabarti (Sakti Chakrabarti)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Topics

Systematic Review

Circulating Tumor

Top Venues

JCO precision oncology

Pharmacogenomics

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Amit Mahipal, Michael Harrison Storandt, Emily A Teslow, Ellen B Jaeger, Melissa C Stoppler, Zhaohui Jin, Sakti Cjakrabarti
Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies. Cancers 16 (10) (2024)
Hanna H Kakish, Fasih Ali Ahmed, Lee M Ocuin, Jennifer L Miller-Ocuin, Emily Steinhagen, Richard S Hoehn, Amit Mahipal, Christopher W Towe, Sakti Cjakrabarti
Outcome of Patients with Locally Advanced Rectal Cancer Pursuing Non-Surgical Strategy in National Cancer Database. Cancers 16 (12) (2024)
Amit Mahipal, Michael Harrison Storandt, Emily A Teslow, Ellen B Jaeger, Melissa C Stoppler, Zhaohui Jin, Sakti Cjakrabarti
Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies. Cancers 16 (10) (2024)
Hanna H Kakish, Fasih Ali Ahmed, Lee M Ocuin, Jennifer L Miller-Ocuin, Emily Steinhagen, Richard S Hoehn, Amit Mahipal, Christopher W Towe, Sakti Cjakrabarti
Outcome of Patients with Locally Advanced Rectal Cancer Pursuing Non-Surgical Strategy in National Cancer Database. Cancers 16 (12) (2024)
Sakti Cjakrabarti, Amit Mahipal
Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer. Pharmacogenomics 24 (1) (2023)
Sakti Cjakrabarti, Amit Mahipal
Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer. Pharmacogenomics (2023)
Anusha Chidharla, Eliot Rapoport, Kriti Agarwal, Samragnyi Madala, Brenda Linares, Weijing Sun, Sakti Cjakrabarti, Anup Kasi
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (12) (2023)
Anusha Chidharla, Eliot Rapoport, Kriti Agarwal, Samragnyi Madala, Brenda Linares, Weijing Sun, Sakti Cjakrabarti, Anup Kasi
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (12) (2023)
Sakti Cjakrabarti, Amit Mahipal
Circulating Tumor DNA-Guided Recurrence Risk Assessment in Esophageal and Gastric Cancer: Assay Holds the Key. JCO precision oncology 7 (2023)
Sakti Cjakrabarti, Amit Mahipal
Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer. Pharmacogenomics 24 (1) (2023)
Tucker W Coston, Aakash P Desai, Hani M Babiker, Mohamad Bassam B Sonbol, Sakti Cjakrabarti, Amit Mahipal, Robert R McWilliams, Wen Wee Ma, Tanios S Bekaii-Saab, John A Stauffer, Jason S Starr
Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience. JCO precision oncology 7 (2023)
Julia C F Quintanilha, Michael H Storandt, Ryon P Graf, Gerald Li, Rachel B Keller, Douglas I Lin, Jeffery S Ross, Richard S P Huang, Alexa B Schrock, Geoffrey R Oxnard, Sakti Cjakrabarti, Amit Mahipal
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness. JCO precision oncology 7 (2023)
Anusha Chidharla, Eliot Rapoport, Kriti Agarwal, Samragnyi Madala, Brenda Linares, Weijing Sun, Sakti Cjakrabarti, Anup Kasi
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (12) (2023)
Sakti Cjakrabarti, Udhayvir Singh Grewal, Kruti Bhagirath Vora, Aparna Raj Parikh, Diana Almader-Douglas, Amit Mahipal, Mohamad Bassam B Sonbol
Outcome of Patients With Early-Stage Mismatch Repair Deficient Colorectal Cancer Receiving Neoadjuvant Immunotherapy: A Systematic Review. JCO precision oncology 7 (2023)
Sakti Cjakrabarti, Amit Mahipal
Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer. Pharmacogenomics 24 (1) (2023)
Sakti Cjakrabarti, Amit Mahipal
Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer. Pharmacogenomics 24 (1) (2023)
Sakti Cjakrabarti, Amit Mahipal
FOxTROT Study Results: Some Burning Questions Need Answers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sakti Cjakrabarti, Amit Mahipal
Circulating Tumor DNA-Guided Recurrence Risk Assessment in Esophageal and Gastric Cancer: Assay Holds the Key. JCO precision oncology 7 (2023)
Amr Mohamed, Sulin Wu, Mohamed Hamid, Amit Mahipal, Sakti Cjakrabarti, David Bajor, J Eva Selfridge, Sylvia L Asa
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines. Cancers 15 (1) (2022)
Amr Mohamed, Sulin Wu, Mohamed Hamid, Amit Mahipal, Sakti Cjakrabarti, David Bajor, J Eva Selfridge, Sylvia L Asa
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines. Cancers 15 (1) (2022)
Sakti Cjakrabarti, Anup Kumar Kasi, Aparna R Parikh, Amit Mahipal
Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC). Cancers 14 (13) (2022)
Sakti Cjakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill, Hiba Dada, Regina Resta, Stephanie Wagner, Naomi Fei, Pashtoon Murtaza Kasi
Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer. Journal for immunotherapy of cancer 10 (6) (2022)
Sakti Cjakrabarti, Mandana Kamgar, Amit Mahipal
Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities. Cancers 14 (11) (2022)
Sakti Cjakrabarti, Heidi D Finnes, Amit Mahipal
Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management. Expert opinion on drug metabolism & toxicology 18 (1) (2022)
Amr Mohamed, Sulin Wu, Mohamed Hamid, Amit Mahipal, Sakti Cjakrabarti, David Bajor, J Eva Selfridge, Sylvia L Asa
Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines. Cancers 15 (1) (2022)
Sakti Cjakrabarti, Mandana Kamgar, Amit Mahipal
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm. Cancers 12 (8) (2020)